Copyright
©The Author(s) 2019.
World J Clin Cases. Feb 26, 2019; 7(4): 452-465
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Table 1 Clinical characteristics
1.2 L PEG-ASC (n = 156) | PEG-ELS (n = 156) | Total (n = 312) | P value | |
Age (mean, range) | 62.6 (19-89) | 63.5 (24-89) | 63.0 (19-89) | 0.21 |
Sex (male, %) | 93 (59.6) | 84 (53.8) | 177 (56.7) | 0.30 |
Constipation, n (%) | 39 (25.0) | 38 (24.4) | 77 (24.7) | 0.89 |
Abdominal operation, n (%) | 58 (37.2) | 55 (35.3) | 113 (36.2) | 0.72 |
Hypertension, n (%) | 36 (23.1) | 26 (16.7) | 62 (19.9) | 0.16 |
Diabetes, n (%) | 12 (7.7) | 15 (9.6) | 27 (8.7) | 0.54 |
Experience of colonoscopy, n (%) | 89 (57.0) | 87 (55.8) | 176 (56.4) | 0.81 |
Indications for colonoscopy, n (%) | ||||
Occult blood test-positive | 76 (48.7) | 70 (44.9) | 146 (46.8) | 0.50 |
Surveillance | 30 (19.2) | 27 (17.3) | 57 (18.3) | 0.66 |
Screening | 21 (13.5) | 22 (14.1) | 43 (13.8) | 0.87 |
Blood in stool | 10 (6.4) | 13 (8.3) | 23 (7.4) | 0.52 |
Abdominal pain | 5 (3.2) | 6 (3.9) | 13 (4.2) | 0.76 |
Constipation | 4 (2.6) | 5 (3.2) | 9 (2.9) | 0.74 |
Diarrhea | 2 (1.3) | 5 (3.2) | 7 (2.2) | 0.44 |
Other reason | 8 (5.1) | 8 (5.1) | 16 (5.1) | 0.80 |
Table 2 Successful cleansing rates according to colonic segment % (n)
1.2 L PEG-ASC (n = 148) | PEG-ELS (n = 143) | P value | |
Right | 93.9 (139) | 94.4 (135) | 0.86 |
Transverse | 95.9 (142) | 95.1 (136) | 0.73 |
Left | 95.9 (142) | 92.3 (132) | 0.19 |
Over all | 91.9 (136) | 90.2 (129) | 0.61 |
Table 3 Successful cleansing rates according to various factors % (n)
1.2 L PEG-ASC | PEG-ELS | P-value | |
Age (70 years old and older) | 89.8 (44) | 89.6 (43) | 0.77 |
Sex (Female) | 93.2 (55) | 87.7 (57) | 0.46 |
Constipation | 81.1 (30) | 88.6 (31) | 0.58 |
Diabetes | 83.3 (10) | 81.3 (13) | 0.72 |
History of abdominal operation | 93.1 (54) | 92.7 (51) | 0.77 |
Table 4 The Polyp detection rate, the adenoma detection rate, and the advanced adenoma detection rate % (n)
Variable | 1.2 L PEG-ASC (n = 148) | PEG-ELS (n = 143) | P value |
PDR | 42.6 (63) | 47.6 (68) | 0.39 |
ADR | 34.5 (51) | 39.1 (56) | 0.41 |
AADR1 | 10.8 (16) | 13.2 (19) | 0.52 |
Table 5 Adverse events % (n)
1.2 L PEG-ASC | PEG-ELS | P value | |
Nausea | 6.1 (9) | 12.6 (18) | 0.087 |
Vomiting | 0.7 (1) | 2.8 (4) | 0.34 |
Abdominal discomfort | 9.5 (14) | 7.7 (11) | 0.59 |
Abdominal pain | 2.7 (4) | 3.5 (5) | 0.96 |
Dizziness | 0 (0) | 2.1 (3) | 0.23 |
Chill | 1.4 (2) | 2.1 (3) | 0.97 |
No discomfort | 81.8 (120) | 76.2 (109) | 0.31 |
- Citation: Tamaki H, Noda T, Morita M, Omura A, Kubo A, Ogawa C, Matsunaka T, Shibatoge M. Efficacy of 1.2 L polyethylene glycol plus ascorbic acid for bowel preparations. World J Clin Cases 2019; 7(4): 452-465
- URL: https://www.wjgnet.com/2307-8960/full/v7/i4/452.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i4.452